Overview

Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis

Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy, acceptability, and safety of vaginal estrogen cream and platelet-rich plasma in pt. complaining of atrophic vaginitis.
Phase:
Phase 1
Details
Lead Sponsor:
Fayoum University
Treatments:
Estrogens
Estrogens, Conjugated (USP)